Observations from the Sarbanes-Oxley trenches
With Section 404 effective dates right around the corner, wide speculation is that many companies’ material weaknesses in Sarbanes-Oxley compliance will be tied to IT deficiencies....
With Section 404 effective dates right around the corner, wide speculation is that many companies’ material weaknesses in Sarbanes-Oxley compliance will be tied to IT deficiencies....
Carol Bartz, the CEO of Autodesk, was inducted into the University of Wisconsin Madison's Entrepreneur Hall of Fame on Tuesday....
I never cease to be amazed by the games that some companies play with their customers in their neverending quest to goose up revenues and shore up profits....
About 75 percent of large-cap Midwest life science stocks did well in the third quarter in a weak market, but some of the largest Big Pharma companies foundered....
Business contacts that Langley brought back to Wisconsin have had a positive impact on the state’s economy....
If you miss getting a flu shot this season and you want to fix blame when you're on your sickbed, take a look in the mirror. ...
Finding online information about your competitors is easy. The difficult part is finding meaning. When researching the competition, you can avoid pitfalls by seeking “intelligence” instead of “information.”...
This is the first of a series of columns in which Byron Glick will ask Wisconsin CIOs for their views and advice on IT leadership and the challenges they face....
For reasons that range from the culture of its people to the size of its congressional delegation, Wisconsin is not a magnet for federal dollars....
MADISON—In the first debate of Wisconsin's U.S. Senate campaign, Republican Tim Michels dismissed scientific research using human embryonic stem cells as little more than an inconsequential sideshow. Michels said he supports the “99 percent” of stem cell research that uses adult...